Status:
NOT_YET_RECRUITING
An Exploratory Clinical Investigation Evaluating Two Abutment Surfaces
Lead Sponsor:
Studio Ban Mancini Fabbri
Conditions:
Peri-implant Crevicular Fluid
Eligibility:
All Genders
Phase:
NA
Brief Summary
A total of 22 subjects will be included in the study. The subjects who were treated with NobelActive TiUnite and On1 machined abutment will be enrolled in the control group and subjects who were treat...
Detailed Description
The main objective of the study is to evaluate the clinical, microbiological, and immunological biomarkers of implant sites which were treated with two different implant-abutment-systems (anodized sur...
Eligibility Criteria
Inclusion
- Subjects willing to sign the Informed Consent Form
- Subjects able to adhere to the investigation schedule
- Subjects with no previous surgical intervention or soft tissue complications in the area of the implant site (e.g., localized mucositis, mild peri-implantitis, etc.) within 3 months before first sample collection
- Subjects regularly adhere to a professional oral hygiene maintenance program
- No recent antibiotics or biological therapy (or any treatment that activates or suppresses the immune system)
- No xerostomia
Exclusion
- Subject not willing to sign the Informed Consent Form
- Subject not able to adhere to the investigation schedule
Key Trial Info
Start Date :
December 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2025
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT06557447
Start Date
December 1 2024
End Date
April 1 2025
Last Update
August 16 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.